Release of provisional recommendations for expert advisory committees

What are we doing?

We are trialing publishing the provisional advice recommendations within 30 business days of advisory committee meetings. 

We started with the May 2025 meeting of the Pharmacology and Therapeutics Advisory Committee (PTAC). Any feedback we receive will help us improve what we do. We will review the value of providing these provisional recommendations and implement a final process.

This pilot is in response to requests for greater transparency.

What information will be shared?

We will share a summary table of provisional recommendations. 

We are releasing provisional recommendations only at this time, which share the high-level outcome of the advice recommendation. 

The detail, which explains the recommendation, will be shared when the full meeting record is completed. 

We understand that sometimes there may be a good reason not to share a provisional recommendation with no supporting information available. 

Applicants and suppliers are given the opportunity to withhold the provisional recommendation until more information is available.